Lv6
2540 积分 2022-05-23 加入
The state of the art in secondary pharmacology and its impact on the safety of new medicines
23小时前
已完结
Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes
3年前
已完结
Novel drug targets in 2021
3年前
已完结
皖公网安备34019202002308
